Edesa Biotech's total assets for Q3 2025 were $14.80M, a decrease of -10.02% from the previous quarter. EDSA total liabilities were $672.67K for the fiscal quarter, a -26.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.